For cash (domestic)
| Company | Marinomed Biotech AG |
|---|---|
| ISIN | ATMARINOMED6 |
| from1 | 1,839,940 |
| by1 | 159,039 |
| to1 | 1,998,979 |
| Date | 04/20/2026 |
| Market | Official Market |
| Market segment | standard market continuous |
| Company | Lenzing AG |
| ISIN | AT0000644505 |
| from1 | 38,618,180 |
| by1 | 34,756,362 |
| to1 | 73,374,542 |
| Date | 10/23/2026 |
| Market | Official Market |
| Market segment | prime market |
Capital increase (foreign)
| Unternehmen | INCERGO S.A. |
|---|---|
| ISIN | LU1917297225 |
| von1 | 141,223,287 |
| um1 | 5,060,000 |
| auf1 | 146,283,287 |
| Datum | 02/19/2026 |
| Markt | Vienna MTF |
| Marktsegment | direct market |
| Unternehmen | ReGuest S.p.A. |
| ISIN | IT0005618803 |
| von1 | 15,000,000 |
| um1 | 224,720 |
| auf1 | 15,224,720 |
| Datum | 03/09/2026 |
| Markt | Vienna MTF |
| Marktsegment | direct market plus |
| Unternehmen | Icona Technology SpA |
| ISIN | IT0005465528 |
| von1 | 7,735,500 |
| um1 | 120,000 |
| auf1 | 7,855,500 |
| Datum | 08/27/2026 |
| Markt | Vienna MTF |
| Marktsegment | direct market |
| Unternehmen | INCERGO S.A. |
| ISIN | LU1917297225 |
| von1 | 146,283,287 |
| um1 | 5,000,000 |
| auf1 | 151,283,287 |
| Datum | 09/18/2026 |
| Markt | Vienna MTF |
| Marktsegment | direct market |
Overview of corporate actions
Capital increases
Stock splits and reverse stock splits
Capital decreases
Capital adjustments
More on listed companies
Companies list
New listings
Corporate actions
Delistings
Investor relations services
Investors